Bluebird Bio (NQ: BLUE )
0.6887
+0.0117
(+1.73%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
All News about Bluebird Bio![]() ![]() ![]() ![]() ![]() ![]() Via Benzinga
![]() ![]() ![]()
(BLUE) - Analyzing bluebird bio's Short Interest
February 29, 2024
Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]()
Is CRISPR Therapeutics the NVIDIA of gene editing?
February 26, 2024
Via MarketBeat
Topics
Artificial Intelligence
![]() ![]() ![]()
Gene Therapy For Beta-Thalassemia: CRISPR Therapeutics/Vertex's Casgevy Secures FDA Nod Ahead of Schedule
January 17, 2024
Via Benzinga
Exposures
Product Safety
![]()
2 Red Flags for Bluebird Bio Stock
January 10, 2024
Via The Motley Fool
![]() ![]() ![]() ![]() From bluebird bio, Inc.
Via Business Wire
![]() ![]() ![]() ![]() ![]() ![]()
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 21, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|